Study With Heparin Sodium in Intravenous Administration

Phase 1 Suspended 24 enrolled Uniao Quimica Buranello e Rodrigues Consultoria em Desenvolvimento Farmacêutico Ltda ME · collab

RandomizedCrossoverOpen-labelOther

Summary

The purpose of this phase I study is to know the pharmacodynamic profile in in intravenous application in humans of the sodium heparin of porcine origin of the company União Química, building from the pharmacodynamic data generated its pharmacokinetic profile, due to the dosage limitation of heparin directly in biological samples. In addition, the toxicity of the product will be evaluated in healthy male participants.

Timeline

Start: 2021-02-20
Primary completion: 2021-02-20
Completion: 2022-11-10

Outcome

Outcome not reported

Stopped: “Delay in the R\&D stage”

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Heparin	Other / unclassified	—	Intravenous

Indications

No indication recorded.